Customer Publication
![](https://www.tandfonline.com/na101/home/literatum/publisher/tandf/journals/content/kmab20/2020/kmab20.v012.i01/19420862.2020.1850394/20220421/images/medium/kmab_a_1850394_f0004_oc.jpg)
Monoclonal antibody 2C5 specifically targets neutrophil extracellular traps
Journal: mAbs (2020)
Institution: Northeastern University
Research Areas: Cell Research
Cell Lines: HL-60 (Human leukemia cell line)
Summary: Neutrophil extracellular traps (NETs) are a defense mechanism against pathogens, such as bacteria, they have also been implicated as an important part of a wide range of pathologies, such as protecting tumor cells from T lymphocytes and natural killer cells; involved in acute thrombotic complications in cardiovascular and autoimmune disease, and most recently it was shown that NETs may contribute to organ damage and mortality in COVID-19. Thus, it is important to detect and remove NETs when their pathological role becomes dominant. In this publication, L. P. Mendes with colleagues have developed a method to visualize and detect NET-affected areas using 2C5 antibody modified nanocarriers. Authors have employed HoloMonitor M4 to study HL-60 cell morphology after treatment with differentiation agents.